Profile
Gregor Siebert is currently a Member-Supervisory Board at PAION AG.
Previously, he worked as the Head of Marketing & Sales at curasan AG from 2015 to 2021.
He also held a position as the Head of Marketing & Sales at G.L.
Pharma GmbH.
Mr. Siebert completed his undergraduate degree at the University of Bonn.
Gregor Siebert active positions
| Companies | Position | Start |
|---|---|---|
| PAION AG | Director/Board Member | 2023-09-29 |
Former positions of Gregor Siebert
| Companies | Position | End |
|---|---|---|
| CURASAN AG | Sales & Marketing | 2021-11-30 |
G.L. Pharma GmbH
 G.L. Pharma GmbH Pharmaceuticals: MajorHealth Technology G.L. Pharma GmbH manufactures and distributes pharmaceutical products. It offers generics for cardiovascular system, central nervous system, urology, oncology, and opioid substitution therapy. The company was founded in 1947 and is headquartered in Lannach, Austria. | Sales & Marketing | - |
Training of Gregor Siebert
| University of Bonn | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PAION AG | Health Technology |
| Private companies | 2 |
|---|---|
curasan AG
 curasan AG Pharmaceuticals: MajorHealth Technology curasan AG engages in the developing, manufacturing and marketing of regenerative medicine. Its products cover the fields of bone and tissue regeneration, tissue engineering, and wound healing for dental, spinal and orthopedic applications. The company was founded by Hans Dieter Rössler in 1988 and is headquartered in Frankfurt, Germany. | Health Technology |
G.L. Pharma GmbH
G.L. Pharma GmbH Pharmaceuticals: MajorHealth Technology G.L. Pharma GmbH manufactures and distributes pharmaceutical products. It offers generics for cardiovascular system, central nervous system, urology, oncology, and opioid substitution therapy. The company was founded in 1947 and is headquartered in Lannach, Austria. | Health Technology |
- Stock Market
- Insiders
- Gregor Siebert
